姓名：劉福生   性別：男   職稱：教授

招生類型：科學與專業學位(碩) 科學與專業學位(博)

招生專業：外科學（神外）(碩) 外科學（神外）(博)

研究方向：膠質瘤的基礎和臨床

電子信箱：liufushengs@hotmail.com

社會任職

1. 《中華診斷學電子雜志》 編委

2. 生物醫學材料-北京實驗室 專家委員會委員

3. 北京市衛生系統高層次衛生技術人才 神經外科學科帶頭人

4. 《中華腦科疾病與康復雜志（電子版）》審稿專家

5. 《中華臨床醫師雜志（電子版）》 特邀審稿專家

6. 《中華臨床醫師雜志（電子版）》 編委

7. 《藥品評價》常務編委

個人簡歷

1. 200411-      :北京市神經外科研究所腦腫瘤研究中心及首都醫科大學附屬北京天壇醫院神外六病房 腦腫瘤研究中心主任；教授、主任醫師、 研究員

2. 200205-200411:美國國立衛生研究院（National Institutes of Health,NIH) 博士后

3. 200107-200205:北京市神經外科研究所及首都醫科大學附屬北京天壇醫院神外 副研究員

4. 199909-200107:首都醫科大學臨床醫學博士后流動站 博士后

5. 199609-199907:山東醫科大學神經外科博士學位研究生 獲博士學位

6. 199307-199608:濰坊醫學院附屬醫院神經外科 主治醫師

7. 199009-199307:山東醫科大學神經外科碩士學位研究生 獲碩士學位

8. 198707-199009:濰坊市益都中心醫院 住院醫師

9. 198209-198707:濰坊醫學院醫療系 學生，獲學士學位

重要學術論文

1. Zhang Q, Wang Y, Liu F*.Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.Cell Signal.2023.103.110567.SCI

2. Wang P, Zhang J, Zhang Q, Liu F *.Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.Biomed Pharmacother.2023.157.114035.SCI

3. Liu SS, Li MX, Sun FQ, Zhang JW, Liu FS *.Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma.J Cancer Res Clin.2023.149(2).901-912.SCI

4. Zhang JW, Wang JL, Li M, Su XD, Tian YF, Wang PW, Zhou XZ, Jin GS, Liu FS *.Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma.Cell Signal.2023.103.110581.SCI

5. Su X, Xie Y, Zhang J, Li M, Zhang Q, Jin G, Liu F*.HIF-alpha activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.Cell Death Dis.2022.13(1).861.SCI

6. Zhang Q, Zhang J, Wang P, Zhu G, Jin G, Liu F *.Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.Stem cell research & therapy.2022.13(1).284.SCI

7. Guidong Zhu, Junwen Zhang, Qing Zhang, Guishan Jin, Xiaodong Su, Sisi Liu, Fusheng Liu*.Enhancement of CD70?specific CAR T treatment by IFN?γ released from oHSV?1?infected glioblastoma.Cancer Immunology, Immunotherapy.2022.71(10).2433-2448.SCI

8. Ruifang Mi, Jiayu Ji, Mengmeng Zhang, Junwen Zhang, Mingxin Li, Yuedong Hu, Fusheng Liu*.Establishment of the glioma polyploid giant cancer cell model by a modified PHA-DMSO-PEG fusion method following dual drug-fluorescence screening in vitro.Journal of Neuroscience Methods.2022.368.109462.SCI

9. Xiangming Han, Qiyan Wang, Sheng Fang, Jialin Wang, Fusheng Liu, Junwen Zhang* and Guishan Jin*.P4HA1 regulates CD31 via COL6A1 in the transition of glioblastoma stem-like cells to tumor endothelioid cells.Frontiers in Oncology.2022.12.836511.SCI

10. Sisi Liu, Junwen Zhang, Sheng Fang, Qing Zhang, Guidong Zhu, Yifu Tian, Mingwei Zhao*, Fusheng Liu*.Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model.Experimental EyeResearch.2021.202.108285.SCI

11. Chengyuan Dong, Sheng Hong, Diwei Zheng, Qianxiao Huang, Fusheng Liu*, Zhenlin Zhong*, Xianzheng Zhang*.Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.Small.2021.17.e2006582.SCI

12. Zhu G, Zhang Q, Zhang J, Liu F*.Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment.Front Pharmacol.2021.12.661606.SCI

13. Wang Q, Zhang J, Fang S, Wang J, Han X, Liu F*, Jin G*.P4HA1 Down-Regulation Inhibits Glioma Invasiveness by Promoting M1 Microglia Polarization.Onco Targets Ther.2021.14.1771-1782.SCI

14. 季佳宇，王啟儼，方勝，田毅夫，劉福生，米蕊芳*.EA-IL-15溶瘤腺病毒的構建及其對膠質瘤細胞特異性及有效性研究.醫學研究雜志.2020.49（10）.47-51.核心期刊

15. 張夢夢，張俊文，米蕊芳，金貴善，劉福生*.siRNA干擾BTN3A3對腦膠質瘤細胞凋亡作用的研究.中華神經外科雜志.2020.36（9）.951-956.核心期刊

16. 方勝, 張俊文, 董程遠, 田毅夫, 王啟儼, 劉福生, 金貴善*.P4HA1調控EMT影響腦膠質瘤侵襲性研究.中國科學: 生命科學.2020.50（4）.446-457.核心期刊

17. Qing Zhang, Junwen Zhang, Yifu Tian, Guidong Zhu, Sisi Liu and Fusheng Liu*.Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cell.Cell Bioscience.2020.10.124（1-12）.SCI

18. Shiqi Hu#, Chengyuan Dong#, Jinqiang Wang, Kexin Liu, Quan Zhou, Jiajia Xiang, Zhuxian Zhoua*, Fusheng Liu*, Youqing Shen*.Assemblies of indocyanine green and chemotherapeutic drug to cure established tumors by synergistic chemo-photo therapy.Journal of Controlled Release.2020.324.250-259.SCI

19. Sisi Liu, Junwen Zhang, Sheng Fang, Xiaodong Su, Qing Zhang, Guidong Zhu, Li Zhu, Mingwei Zhao*, Fusheng Liu*.Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.Cancer Letters.2020.495.123-134.SCI

20. Qing Zhang and Fusheng Liu*.Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas.Cell Death & Disease.2020.11:485.1-11.SCI

21. Junwen Zhang#, Sheng Fang#, Wenjie Song, Bo Zhang, Wenhua Fan, Guishan Jin, Fusheng Liu*.Biological Characterization and Therapeutics for Subscalp Recurrent in Intracranial Glioblastoma.OncoTargets and Therapy.2020.13.9085-9099.SCI

22. Ruifang Mi, Wenhua Fan, Jiayu Ji, Chengyuan Dong, Guishan Jin, Fusheng Liu*.The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma.Brain Research.2020.1743.146898（1-9）.SCI

23. Sisi Liu, Fusheng Liu, Mingwei Zhao, Junwen Zhang*.Antitumor efficacy of Oncolytic herpes virus type I armed with GM-CSF in murine uveal melanoma xenografts.Cancer Management and Research.2020.12.1-10.SCI

24. 張夢夢，蘇曉東，田毅夫，季佳宇，劉福生*.BTN3A3低表達促進肝細胞癌的惡性進展.醫學研究雜志.2020.49（4）.75-80.核心期刊

25. Yiqiang Zhou, Yang Liu, Junwen Zhang, Di Yu, Aiguo Li, Hua Song, Wei Zhang, Dionne Davis, Mark R. Gilbert, Fusheng Liu*, and Chunzhang Yang*.Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas.Translational Oncology.2020.13（2）.125-134.SCI

26. Quan Zhou, Chengyuan Dong, Wufa Fan, Haiping Jiang, Jiajia Xiang, Nasha Qiu,Ying Piao, Tao Xie, Yingwu Luo, Zichen Li, Fusheng Liu, Youqing Shen?.Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.Biomaterials.2020.240.119902.SCI

27. Fan-Wei Meng, Fu-Sheng Liu, Wen-Hui Liu, Li Li and Lin-Lin Jie.Formation of new lymphatic vessels in glioma: An immunohistochemical analysis.Neuropathology.2020.40(3）.215-223.SCI

28. Chengyuan Dong, Junwen Zhang, Sheng Fang and Fusheng Liu*.IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells.Cell Division.2020.15.4.SCI

29. Chengyuan Dong, Quan Zhou, Jiajia Xiang*, Fusheng Liu*, Zhuxian Zhou*, Youqing Shen.Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy.Journal of Controlled Release.2020.321.529-539.SCI

30. 張俊文，范文華，方勝，陳虹，黃秉仁，劉福生*.shRNA干擾eIF4A1基因對膠質瘤細胞體內外生物學特征的影響.中國科學: 生命科學.2019.49.987-995.核心期刊

31. 張俊文，趙喬佳杰，楊霞，馬雯，黃秉仁，劉福生*.RanBPM調控IFNlR1-STAT5通路分子機制研究.醫學研究雜志.2019.48（8）.31-36.核心期刊

32. Bo Zhang#, Junwen Zhang#, Sheng Fang, Mengmeng Zhang, Sisi Liu, Yifu Tian, Mengjiao Ma, Fusheng Liu, Guishan Jin*. Inflammatory activation of microglia by Staphylococcus aureus caused phenotypic alterations and affected glioblastoma growth.Cell Biochem Funct.2019.1-9.DOI: 10.1002/cbf.3396.SCI

33. Zhang J, Cui B, Chen H, Huang BR*, Liu F*.eIF4A1 is associated with TrkA and inhibits TrkA polyubiquitination.Prog. Biochem, Biophys.2019.46（8）.812-822.SCI

34. Wenhua Fan, Meiyu Shao, Junwen Zhang, Guishan Jin, Fu-Jian Xu,* and Fusheng Liu*.Hybrid nanovector of suicide gene engineered lentivirus coated with bioreducible polyaminoglycosides for enhancing therapeutic efficacy against glioma.Adv. Funct. Mater..2019.29.1807104.SCI

35. 劉福生，李小鵬，田超，張俊文.TSPO在治療腦膠質瘤中的應用及重組單純皰疹病毒及其制備方法和應用。國家發明專利，專利號：ZL 2017 1 1251406.7.中華人民共和國國家知識產權局.2019. . .

36. 張俊文，劉福生，方勝，宋文杰.一種人腦膠質瘤細胞系及其建立方法和應用.國家發明專利，專利號：ZL 2018 1 1535397.9.中華人民共和國國家知識產權局.2019. . .

37. 張昀昇，張俊文，米蕊芳，周益強，程森，宋文杰，劉福生，金貴善*.TRIM33對人腦膠質瘤U251細胞生物學功能影響的實驗研究.中華神經外科雜志.2018.34（3）.292-298.核心期刊

38. Sisi Liu #, Wenjie Song #, Fusheng Liu2, Junwen Zhang2*, Siquan Zhu1*.Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.Experimental Eye Research.2018.172.144-151.SCI

39. Yunsheng Zhang#, Guishan Jin#, Junwen Zhang, Ruifang Mi, Yiqiang Zhou, Wenhua Fan, Sen Cheng, Wenjie Song, Bo Zhang, Mengjiao Ma, Fusheng Liu*.Overexpression of STAT1 suppresses angiogenesis under hypoxia by regulating VEGF?A in human glioma cells.Biomedicine & Pharmacotherapy.2018.104.566-575.SCI

40. 徐恒周，金貴善，米蕊芳，張俊文，周益強，劉福生*.FASN在腦膠質瘤組織中的表達及其臨床意義.中華神經醫學雜志.2017.16（3）.217-221.核心期刊

41. Liu J, Wang Y, Sun X, Ji N, Sun S, Wang Y, Liu F, Cui Q, Wang C#, Liu Y#.Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.Oncology reports.2017.37.887-894.SCI

42. JW Zhang XJ Cong, J Zhao, X Yang, M Li, H Chen, FS Liu, *, BR Huang*.Ran bingding protein 9(RanBPM)binds IFN-λR1 in the IFN-λ signaling pathway.Sci China Life Sci.2017.60（9）.1030-1039.SCI

43. Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F*.Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.Oncotarget.2017.8（22）.35877-35889.SCI

44. Sen Cheng#,Ruifang Mi #, Yu Xu,Guishan Jin,Junwen Zhang, Yiqiang Zhou,Zhengguang Chen, Fusheng Liu*.Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts.J Cancer Res Clin Oncol .2017.143（6）.941-951.SCI

45. 張俊文，叢曉杰，趙喬佳杰，楊霞，李夢，陳虹，米蕊芳，金貴善，黃秉仁，劉福生*.RanBPM結合干擾素γ信號通路中的干擾素受體1.中國科學 生命科學.2017.47（7）.718-727.核心期刊

46. Guobin Zhang, Yunsheng Zhang, Sen Cheng, Zhen Wu, Fusheng Liu*, Junting Zhang*.CD133 positive U87 glioblastoma cells-derived exosomal microRNAs in hypoxia- versus normoxia-microenviroment.J Neuro-oncol.2017.135.37-46.SCI

47. 張俊文,杜延順,米蕊芳,陳虹,劉福生*,黃秉仁*.TGF-βRI與Fascin1的相互作用..基礎醫學與臨床.2016.36（3）.315-319.核心期刊

48. 劉福生，金貴善*.對醫學專業學位碩士研究生科研能力培養的思考與體會.醫學教育管理.2016.2（2）.438-440.核心期刊

49. 米蕊芳，金貴善，張俊文，周益強，徐恒周，程森，劉福生*.VP22-CD基因工程化載體對膠質瘤細胞體外殺傷作用的研究.中華神經外科雜志.2016.6（32）.614-618.核心期刊

50. Mi RF, Pan CX, Zhou YQ, Liu YB, Jin GS*, Liu FS*.Identification of the metastasis potential and its associated genes in melanoma multinucleated giant cells using the PHA-ECM830 fusion method.Oncology reports.2016.35（1）.211-218.SCI

51. Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H, Cheng S, Zhang Y, Song W, Liu F*.Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma.J Cancer Res Clin Oncol.2016.142.2447-2459.SCI

52. 張俊文，劉福生*.醫學基礎學科研究生科學實驗與研究能力培養方式探討.醫學教育管理.2016.2（supp2）.121-123.核心期刊

53. 金貴善，劉福生*.醫學碩士研究生創新能力培養的分析和思考.醫學教育管理.2016.2（supp2）.118-120.核心期刊

54. Yang Hu#, Yiqiang Zhou#, Nana Zhao, Fusheng Liu*, and Fu-jiang Xu*.Multifunctional pDNA-conjugated polycationic au nanorod-coated Fe3O4 hierarchical nanocomposites for trimodal imaging and combined photothermal/gene therapy.Small.2016.12(18).2459-2468.SCI

55. Nana Zhao, Jia Li, Yiqiang Zhou, Yang Hu, Ranran Wang, Zhaoxia Ji, Fusheng Liu*, Fujian Xu*. Hierarchical Nanohybrids of Gold Nanorods and PGMA-Based Polycations for Multifunctional Theranostics.Advanced functional materials.2016.26.5848-5861.SCI

56. 張國濱，張晉，徐恒周，周益強，程森，劉福生*.支鏈氨基酸氨基轉移酶1在惡性膠質瘤中的表達及意義.中華神經外科雜志.2015.31（12）.1259-1262.核心期刊

57. 張晉，金貴善，米蕊芳，周益強，房紹偉，朱樹干，劉福生*.腦膠質瘤干細胞內皮細胞分化差異基因表達譜的分析.中華神經外科雜志.2015.31（3）.299-303.核心期刊

58. Dong C#, Mi R#, Jin G, Zhou Y, Zhang J, Liu F*.Identification of the proliferative effect of Smad2 and Smad3 in TGFβ2/Smads signal pathway using RNA interference in glioma cell line.Molecular Medicine Reports.2015.12.1824-1828.SCI

59. Zhao Y, Duan S, Yu B, Liu FS, Cheng G, Xu FJ*.Gd(III) ino-chelated supramolecular assemblies composed of PGMA-based polycations for effective biomedical applications.NPG Asia Materials.2015.7.e197.SCI

60. Zhang GB, Jin GS, Nie XT, Mi RF, Zhu Guidong, Liu FS*.Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastomas stem cell xenografts.PLOS ONE.2014.9（4）.e95872.SCI

61. Zhou YQ, Jin GS, Mi RF, Dong CY, Zhang J, Liu FS*.The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells.Brain Research.2014.1556.57-66.SCI

62. Yang Hu, Nana Zhao, Bingran Yu, Fusheng Liu*, Fu-Jian Xu*.Versatile types of Polysaccharide-Based Supramolecular Polycation/pDNA Nanoplexes for Gene Delivery.Nanoscale.2014.6（13）.7560-7569.SCI

63. 周益強， 金貴善，劉福生*.PDGF-B在腦膠質瘤中的研究進展.中華神經外科雜志.2014.30（8）.844-846.核心期刊

64. 張國濱，金貴善，米蕊芳，周益強，董程遠，劉福生*.內皮抑素和血管生成抑素融合基因修飾的單純皰疹病毒對膠質瘤干細胞殺傷作用的實驗研究.中華神經外科雜志 .2014.30（7）.723-728.核心期刊

65. Bin Xu, Dong-Ming Yu*, Fu-Sheng Liu*.Effect of siRNA?induced inhibition of IL?6 expression in rat cerebral gliocytes on cerebral edema following traumatic brain injury.Molecular Medicine Reports.2014.10.1863-1864.SCI

66. 董程遠，金貴善，米蕊芳，周益強，張晉，劉福生*.shRNA干擾技術對腦膠質瘤細胞中TGFβ2/Smads通路的研究.中華神經外科雜志.2014.30（4）.404-408.核心期刊

67. 聶秀濤，金貴善，徐厚池，劉福生*.腦膠質瘤干細胞和血管關系的研究進展.中華神經外科雜志.2014.30(3).315-317.核心期刊

68. 陳寶師，畢智勇，張忠，劉福生*.靶向聯合化療治療原發性中樞神經系統淋巴瘤的研究.中華神經醫學雜志.2014.13（1）.83-85.核心期刊

69. 周益強，金貴善 米蕊芳 董程遠 張晉 劉福生*.血小板源性生長因子B及其基因啟動子區甲基化在腦膠質瘤中的表達及意義.中華神經外科雜志.2014.30(3).288-291.核心期刊

70. Peng Yan, Nana Zhao, Hao Hu, Xinyi Lin, Fusheng Liu, Fujian Xu*.A facile strategy to functionalize gold nanorods with polycation brushes for biomedical applications.Acta Biomater.2014.10（8）.3786-3794.SCI

71. 劉福生.努力提高腦膠質瘤的診治水平.中華臨床醫師雜志.2013.7（14）.6217-6219.核心期刊

72. 聶秀濤，金貴善，米蕊芳，張國濱，謝堅，曹澤，周益強，董程遠，劉福生*.人腦膠質瘤干細胞分化為血管內皮細胞的實驗研究.中華神經外科雜志.2013.29（3）.289-293.核心期刊

73. 米蕊芳，劉福生，金貴善*.多核巨細胞對小鼠黑色素瘤細胞轉移能力的研究.中華臨床醫師雜志.2013.7(14).6457-6461.EI

74. Jin GS, Hao SY, Xie J, Mi RF and Liu FS*.Collision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region.World journal of surgical Oncology.2013.11.178（1-7）.SCI

75. 董程遠，米蕊芳，劉福生*.TGF-beta/Smads 通路中信號轉導蛋白Smad2與Smad3的差異性研究進展.中華臨床醫師雜志.2013.7（14）.6579-6581.核心期刊

76. 米蕊芳，劉福生，金貴善*.植物血凝素-ECM830細胞融合法融合黑色素瘤細胞.中國醫學科學院學報.2013.35（5）.515-518.核心期刊

77. Jin GS, Zhou YQ, Chai Q, Zhu GD, Xu FJ, Liu FS*.VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.journal of cancer research and clinical oncology.2013.139.475-483.SCI

78. 曹澤，金貴善，劉福生*，謝堅.TGF-β2/Smad2 在人腦膠質瘤組織中的表達及意義.中華臨床醫師雜志.2012.6（6）.43-46.核心期刊

79. 金貴善，劉福生*.培養科研型碩士研究生的科研思維.首都醫科大學學報社科版.2012.增刊.353-354.核心期刊

80. 劉福生，金貴善*.指導臨床醫學科研型碩士研究生發表SCI論文.首都醫科大學學報社科版.2012.增刊.355-357.核心期刊

81. Jin GS, Zhu GD, Zhao ZG, Liu FS* .VP22 enhances the expression of gluco-cerebrosidase in human Gauche II fibroblast cells mediated by lentivirus vector.Clinical and experimental medicine.2012.12.135-143.SCI

82. 謝堅，李春德，劉福生*，陸睜，郭而安，張鵬飛，梁雄立，廖浩.經腦外側裂切除島葉膠質瘤.中華神經外科雜志.2011.27（2）.208-209.核心期刊

83. 蘇偉，朱貴東，劉福生*，姜中利，金貴善，柴奇，曹澤，聶秀濤.Smad2基因在人腦膠質瘤的表達及其臨床意義.中華神經外科雜志.2011.27（10）.1064-1068.核心期刊

84. 張國濱，劉福生*、王忠誠.腦膠質瘤干細胞巢的研究進展.中華神經外科雜志.2011.27（12）.1287-1290.核心期刊

85. 蘇偉，劉福生*，朱貴東，姜中利，金貴善，柴奇，曹澤.人腦膠質瘤中轉化生長因子β2、Smad3蛋白表達及臨床意義.中國康復理論與實踐.2011.17（5）.433-436.核心期刊

86. 朱貴東，劉福生*，蘇偉，金貴善，柴奇.內皮抑素和血管生成抑素融合基因修飾的單純皰疹病毒對膠質瘤干細胞的體外實驗研究.中華神經外科雜志.2011.27（9）.949-954.核心期刊

87. 蘇偉，劉福生*，姜中利.TGF-β/smads信號通路與膠質瘤研究進展.中華神經外科雜志.2011.27（3）.322-324.核心期刊

88. Xu FJ, Zhu Y, Chai MY，Liu FS*.Comparison of ethanolamine/ethylenediamine-functionalized poly (glycidyl methacrylate) for efficient gene delivery.Acta Biomaterialia.2011.7.3131-3140.SCI

89. Zhu GD, Su W，Jin GS, Xu FJ, Hao SY, Guan FX, Jia W, Liu FS*.Glioma stem cells targeted by oncolytic virus carrying endostatin-angiostatin fusion gene and the expression of its exogenous gene in vitro.Brain Research.2011.1390.59-69.SCI

90. 朱貴東，劉福生*.溶瘤病毒治療腦膠質瘤新進展.中華神經外科雜志.2010.26（5）.472-474.核心期刊

91. Xu FJ, Zhu Y, Liu FS，Nie J, Ma J, Yang WT.Comb-shaped conjugates comprising hydroxypropyl cellulose and low-molecular-weight poly (N-isopropylacryamide) side chains for smart hydrogeis: sythesis, characterization and biomedical applications..Bioconjugate Chemistry.2010.21(3).456-464.SCI

92. Xu FJ, Chai MY, Li WB, Ping Y, Tang GP, Yang WT, Ma J, Liu FS*.Well-defined poly (2-hydroxyl-3-(2-hydroxyethlamino) propyl methacylate) vectors with low cytotoxicity and high gene transfection efficiency.Biomacromolecules.2010.11(6).1437-1442.SCI

93. 金貴善, 劉福生* ,柴奇, 蘇偉 ,朱貴東.VP22修飾的CD基因工程化干細胞治療大鼠C6膠質瘤體外膠質瘤的研究.中華神經外科雜志.2009.25(11).1039-1043.核心期刊

94. 金貴善，劉福生*，柴奇，蘇偉，朱貴東.慢病毒載體VP22-EGFP的構建及其對大鼠神經干細胞轉染及表達的研究.中華神經外科雜志.2009.25.278-282.核心期刊

95. 王建交，李青松，詹奇，鄭永日，劉福生*.大鼠C6膠質瘤模型構建及生長特性的研究.中國康復理論與實踐.2009.15（8）.742-744.核心期刊

96. 李遠，焦紅亮，官方霞，宋來君，楊波，胡祥，杜英，李惠翔，龐霞，劉福生*，薛敬禮.人羊膜間充質干細胞移植對荷瘤鼠C6膠質瘤生長的抑制.中國組織工程研究與臨床康復.2008.12（51）.10099-10103.核心期刊

97. 王建交，楊立莊，劉福生* ，金貴善，柴奇.內皮抑素和血管生成抑素融合基因的裂解病毒對C6膠質瘤的實驗研究.中華神經外科雜志.2008.24（1）.69-72.核心期刊

98. Zhang Z, Jiang T, Xie J, Liu FS, Li SW, Qiao H, Wang ZC.Surgical strategies for glioma involving language areas..Chinese Medical Journal.2008.121(18).1800-1805.SCI

99. Jin GS, Liu FS*, Chai Q, Wang JJ, Li JH..Stable EGFP gene expression in C6 glioma cell line after transduction with HIV-based lentiviral vector.Chinese Journal of Cancer Research.2008.20.243-248.SCI

100. 金貴善，劉福生*，柴奇，王建交，車樹圣.慢病毒介導的穩定表達綠色熒光蛋白的C6膠質瘤細胞株的建立及其生物學特性的觀察.中華神經外科雜志.2007.23.541-544.核心期刊

101. 車樹圣，孟慶海，金澎，李洛，劉福生*.腦膠質瘤干細胞的體外培養與生物學特性的觀察.山東醫藥.2007.47（15）.1-2.核心期刊

102. Jin GS, Liu FS*, Chai Q, Li JH.Fusions of dendritic cells transfected with TGF-β1 antisense in treatment of intracranial gliomas..Chinese Journal of Cancer Research.2007.19.113-118.SCI

103. 劉福生*，歷俊華，林松，王忠誠.樹突狀細胞與反義TGF-β1基因修飾的膠質瘤細胞融合瘤苗治療腦膠質瘤的實驗研究.中華神經外科雜志.2006.22（1）.47-50.核心期刊

104. 姜中利，王忠誠，江濤，劉福生*.顳葉內側低級別膠質瘤手術治療效果分析.山東大學學報.2006.44（5）.481-483.核心期刊

105. 劉福生，王忠誠.神經干細胞治療腦膠質瘤的研究進展.中華神經外科雜志.2005.22（2）.123-126.核心期刊

106. 張建，張慶林，王成偉，于貽飛，郭華，孔建新，陶榮杰，劉福生*.膠質瘤多藥耐藥細胞株大鼠動物模型的建立及其生物學性質.中國醫學科學院學報.2004.26 （1）.43-46.核心期刊

107. Liu Yuguang, Zhang Liangwen, Liu Fusheng, Zhu Shugan, Li Xingang, Su Wandong, Wu Chengyuan.Chronic expanding intracerebral hematoma.Journal of Clinical Neuroscience.2003.10(6).680–682.SCI

108. 劉福生，歷俊華，王忠誠.膠質瘤免疫治療的新進展.國外醫學免疫學分冊.2003.26（1）.31-33.核心期刊

109. 劉福生，歷俊華，王忠誠.樹突狀細胞細胞株的研究進展.國外醫學免疫學分冊.2002.25（5）.279-282.核心期刊

110. 劉福生，王忠誠，歷俊華，林松，任銘，肖慶，張亞卓.腫瘤抗原致敏樹突狀細胞瘤苗治療顱內膠質瘤的實驗研究.中華神經外科雜志.2002.18（2）.91-95.核心期刊

111. Chen Jianli, Jiang Sen, Yang Ruifang, Liu Fusheng, Sun Xiaoming.Mechanism of drug resistance and reversal with ligustra-zine and cyclosporina in cisplatin-induced human epithelial ovarian cancer resistant cell line 3Ao/cDDP..Chinese Journal of Cancer Research.2002.12(3).197-203.SCI

112. Liu Fusheng*, Wang Zhongcheng, Zhang Qinglin, Li Junhua, Zhang Yazhuo.Establishment of multidrug-resistance cell line C6/adr and reversal of drug resistance.Chinese Medical Journal.2002.115(2).238-241.SCI

113. 劉福生，張亞卓.樹突狀細胞與腫瘤的免疫治療策略.神經疾病與精神衛生.2001.1（1）.3-4.核心期刊

114. 劉福生，張慶林，趙麗，王成偉 ，金澎.膠質瘤多藥耐藥機制的研究.中華外科雜志.2001.39（2）.172.核心期刊

115. 劉福生，張慶林.影響腦膠質瘤化療效果的主要因素.山東醫藥.2001.41（7）.52-53.核心期刊

116. 劉福生，張慶林，卞繼峰，龐琦，王成偉.膠質瘤多藥耐藥細胞系C6/adr的建立及其生物學特性的研究.中華神經外科雜志.2001.17（2）.109-112.核心期刊

117. 劉福生，張慶林，趙麗，王成偉，金澎.腦膠質瘤多藥耐藥細胞系C6/adr的建立及其耐藥性逆轉的研究.中華神經外科雜志.2000.16（5）.320-323.核心期刊

118. 劉福生，張慶林，劉玉光，徐淑軍.慢性擴張性腦內血腫11例報告.山東醫科大學學報.1999.37（2）.156-157.核心期刊

119. 劉福生，張慶林，劉玉光，徐淑軍.慢性擴張性腦內血腫.中華誤診學雜志.1998.1.48-49.核心期刊

120. 劉福生，魏東光，張慶林.HSV-tk /GCV系統基因治療顱內惡性膠質瘤的新進展.中國腫瘤臨床與康復.1998.5（5）.83-84.核心期刊

121. 劉福生，劉百波，丁曉東.顱腦損傷后你慢性腦腫脹18例分析.濰坊醫學院學報.1996.18（3）. .核心期刊

122. 劉福生，張成，劉玉光，楊琳，張慶林.鼠腦內注射rIL-2對腦組織和血腦屏障的影響.濰坊醫學院學報.1995.17（3）.169-171.核心期刊

123. 劉福生，張文東，王在震，劉玉光.過繼性免疫治療顱內轉移瘤1例.山東醫藥.1994.34（11）.62.核心期刊

124. 張文東，劉福生*.IL-2/LAK細胞療法在神經外科的應用.山東醫藥.1994.34（7）.45.核心期刊

125. 楊廷艦，王成偉，匡紹華，劉福生*.凹陷性骨折至竇匯損傷成功止血1例.濰坊醫學院學報.1994.10（4）.266.核心期刊

126. 劉福生，王成偉，匡紹華，楊廷艦，唐衛華.側腦室內神經節神經瘤1例.濰坊醫學院學報.1994.16（4）.262.核心期刊

127. 劉福生，劉玉光.三維CT血管造影診斷腦血管疾病（譯文）.國外醫學神經病學神經外科學分冊.1992.5.279.核心期刊

128. 劉福生，劉玉光.腦室引流與動脈瘤再出血的關系（譯文）.國外醫學神經病學神經外科學分冊.1992.5.280.核心期刊

主編或副主編的著作/譯著

1. 《腦膠質瘤基礎與臨床研究》,主編,人民衛生出版社,201603

2. 《腦膠質瘤》,主編,人民衛生出版社,200704

重要獎項

1. 腦膠質瘤化學治療和生物治療的研究 山東省科學技術進步獎 二等獎 201312

2. 腦膠質瘤化學治療和生物治療的實驗研究 華夏醫學科技獎 二等獎 201208

3. 腦膠質瘤化學治療和生物學治療的實驗研究 山東高等學校優秀科研成果獎 一等獎 201112

4. 腦膠質瘤生物學特性及阻斷膠質瘤耐藥基因的研究 中華醫學科技獎 三等獎 200712

5. 反義寡核苷酸阻斷腦膠質瘤耐藥基因表達的實驗研究 山東省科學技術獎（自然科學獎） 三等獎 200704

6. 腦膠質瘤生物學特性的實驗研究 教育部提名的國家科技進步獎 二等獎 200301

7. 腦膠質瘤生物學特性的研究 山東省科學技術獎（科技進步獎） 一等獎 200209

8. 特殊類型顱內血腫的診斷與治療 山東省科學技術獎（科技進步獎） 三等獎 200209

9. 山東省十大科技成果獎 山東省十大科技成果獎 2002

10. 山東省優秀博士畢業生 山東省優秀博士畢業生 2000